Serum fatty acid-binding protein 4 as a biomarker for early detection of diabetic nephropathy in type 2 diabetes
Abstract Background Diabetic nephropathy (DN) is one of the major causes of ESKD, and its complications are characterized by proteinuria, decreased glomerular filtration, and renal fibrosis resulting in the deterioration of renal functions, so early detection of nephropathy is essential to slow down...
Main Authors: | Amr M. Shaker, Maggie E. Mohamed, Tarek Ramzy, Mayssa I. Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-03-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43162-023-00200-9 |
Similar Items
-
Urinary transferrin as an early biomarker of diabetic nephropathy
by: Terzić Brankica, et al.
Published: (2019-01-01) -
Urinary Retinol Binding Protein (RBP) Level as an early Biomarker of Diabetic Nephropathy in type 2 Diabetic Patients
by: Nilly Abdallah, et al.
Published: (2020-06-01) -
Mechanism of hypertension in diabetic nephropathy
by: Nazar Chaudhary Muhammad Junaid
Published: (2014-04-01) -
Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients
by: Yomna E. Dean, et al.
Published: (2023-11-01) -
Estimation of the Various Urinary Biomarkers among the Non-Hypertensive Type 2 Diabetic Patients with Nephropathy
by: Sudarshan Chakraborty, et al.
Published: (2024-01-01)